Efficacy evaluation of tyrosine kinase inhibitors for advanced non-small cell lung cancer patients with leptomeningeal metastasis
Targeted therapies have demonstrated promising results in LM patients from advanced NSCLC, particularly in those receiving concurrent local leptomeningeal therapy.
Authors
- Chunwei Xu
- Manyi Xu (ORCID: https://orcid.org/0000-0002-6937-3652)
- Yanhua Wang (ORCID: https://orcid.org/0009-0005-4471-1554)
- Liwen Hong (ORCID: https://orcid.org/0000-0003-2164-5003)
- Hao Yue (ORCID: https://orcid.org/0000-0002-8486-8100)
- Zhengbo Song
Institutions
- Zhejiang Chinese Medical University (CN)
- Chinese Academy of Sciences (CN)
- Nanjing General Hospital of Nanjing Military Command (CN)
- Zhejiang Cancer Hospital (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/jtd-2024-2047
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00